Wu, Y., Sun, X., Lv, L., Cui, Q., Qian, J., Xing, R., . . . Liu, Y. Efficacy of individualized orelabrutinib-based regimens in relapsed or refractory central nervous system lymphoma. Frontiers Media S.A.
Chicago Style (17th ed.) CitationWu, Yuchen, et al. Efficacy of Individualized Orelabrutinib-based Regimens in Relapsed or Refractory Central Nervous System Lymphoma. Frontiers Media S.A.
MLA (9th ed.) CitationWu, Yuchen, et al. Efficacy of Individualized Orelabrutinib-based Regimens in Relapsed or Refractory Central Nervous System Lymphoma. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.